108768 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system; T lymphocytes Immunosuppressive T lymphocytes, e.g. regulatory T cells (Treg)
RAPID PRODUCTION, EXPANSION, AND INCREASED PURITY OF CAR-T CELLS USING BEADS WITH PROTEIN L
#302Method of treating a tumor expressing carbonic anhydrase IX (G250) by administering a G250-specific chimeric antigen receptor
#303Veto cells generated from memory T cells
#304Peptide activating agent
#305Drug-Resistant Immune Cells and Methods of Use Thereof
#306GENETIC ENGINEERING OF ENDOGENOUS PROTEINS
#307MODIFIED EPITOPES FOR BOOSTING CD4+ T-CELL RESPONSES
#308CELL
#309CS1 targeted chimeric antigen receptor-modified T cells
#310T regulatory (Treg) cell transplantation in osteogenesis imperfecta (OI)
#311CELL
#312Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
#313COMPOSITIONS AND METHODS FOR MODIFYING REGULATORY T CELLS
#314METHODS FOR INCREASING EXPANSION AND IMMUNOSUPPRESSIVE CAPACITY OF A POPULATION OF CD8+CD45RCLOW/- TREGS
#315METHODS FOR PRODUCING REGULATORY IMMUNE CELLS AND USES THEREOF
#316Engineered regulatory T cell
#317INTRACELLULAR DELIVERY OF BIOMOLECULES TO INDUCE TOLERANCE
#318METHOD FOR LARGE-SCALE PRODUCTION OF HUMAN ALLOSPECIFIC INDUCED-REGULATORY T CELLS WITH FUNCTIONAL STABILITY IN THE PRESENCE OF PRO-INFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#319COMPOSITIONS COMPRISING REGULATORY T CELLS AND METHODS OF MAKING AND USING THE SAME
#320Systems and methods for cell culturing
#321Methods and Materials for the Generation of Regulatory T Cells
#322Systems and methods for cell culturing
#323SYSTEMS AND METHODS FOR CELL CULTURING
#324Systems and methods for cell culturing
#325Systems and methods for cell culturing
#326Systems and methods for cell culturing
#327Compositions and methods for modulating and detecting tissue specific TH17 cell pathogenicity
#328Method for enhancing the suppressive properties of Treg cells
#329strain and strain-derived polysaccharide
#330ACTIVE CXCR4+ IMMUNE CELLS AND METHODS FOR THEIR PRODUCTION AND USE
#331Enhanced immune cells using dual shRNA and composition including the same
#332Expression of FOXP3 in edited CD34+ cells
#333SELECTION METHODS FOR GENETICALLY-MODIFIED T CELLS
#334PLZF+ REGULATORY CD8 T CELLS FOR CONTROL OF INFLAMMATION
#335Cell expansion
#336METHODS OF SELECTING AND DESIGNING SAFER AND MORE EFFECTIVE ANTI-CTLA-4 ANTIBODIES FOR CANCER THERAPY
#337FIXED RATIO EX VIVO ACTIVATED MIXED LYMPHOCYTE PRODUCTS FOR USE IN THE TREATMENT OF CANCER
#338METHOD FOR OBTAINING REGULATORY T CELLS DERIVED FROM THYMIC TISSUE AND USE OF SAID CELLS AS CELL IMMUNOTHERAPY IN IMMUNE SYSTEM DISORDERS
#339IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells
#340Chimeric antigen receptors against multiple HLA-G isoforms
#341GENETICALLY REPROGRAMMED TREGS EXPRESSING MEMBRANE-BOUND IL-10
#342METHODS FOR MANUFACTURING T CELLS
#343Methods for allogenic hematopoietic stem cell transplantation
#344Methods for directed differentiation of pluripotent stem cells to immune cells
#345Fusion Molecules Targeting Immune Regulatory Cells and Uses Thereof
#346T CELLS EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS
#347Methods for allogenic hematopoietic stem cell transplantation
#348CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS
#349Engineered regulatory T cells
#350METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
#351Method for obtaining T cells from pluripotent stem cells, and uses thereof
#352Methods and Compositions for Modulating TH-GM Cell Function
#353In vitro immune synapse system and method of in vitro evaluating immune response using the same
#354METHODS OF EXPANDING T CELLS
#355CAR-T CELLS AND AUTOIMMUNE DISEASES
#356CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS
#357Regulatory T cells genetically modified for the lymphotoxin alpha gene and uses thereof
#358Composition and method for cultivation, expansion, preservation and/or cell pretreatment
#359HIV IMMUNOTHERAPY WITH NO PRE-IMMUNIZATION STEP
#360METHODS FOR IDENTIFYING AND SEPARATING PRO-ALLERGIC SPECIFIC T CELLS
#361Methods for expansion or depletion of T-regulatory cells
#362Controlled Transgene Expression in Regulatory T Cells
#363T-reg cell expansion
#364Regulatory T cell expressing a chimeric antigen receptor
#365T cells surface-loaded with immunostimulatory fusion molecules and uses thereof
#366Methods for obtaining regulatory t cells and uses thereof
#367Regulatory T cell epitopes
#368CTLA-4 variant immunomodulatory proteins and uses thereof
#369METHOD FOR PREPARING ANTIGEN-SPECIFIC REGULATORY T CELLS
#370Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
#371Methods to Expand a T Regulatory Cell Master Cell Bank
#372Compositions and methods for identification of antigen specific T cells
#373Tagged chimeric effector molecules and receptors thereof
#374T cell receptors for immunotherapy
#375IN VITRO IMMUNE SYNAPSE SYSTEM AND METHOD OF IN VITRO EVALUATING IMMUNE RESPONSE USING THE SAME
#376Single-chain chimeric polypeptides and uses thereof
#377Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
#378METHODS FOR GENERATING POLYCLONAL REGULATORY T CELLS
#379Indirect ultrasonic cavitation-derived perivascular cells and methods of use thereof
#380TREATMENT OF LIVER FAILURE WITH ACTIVATED T REGULATORY CELLS
#381Cellular populations and uses thereof
#382TREATMENT METHOD FOR KIDNEY TRANSPLANT REJECTION
#383GAMMADELTA T CELL EXPANSION PROCEDURE
#384γδ T cell expansion procedure
#385Indole regulation of antigen presenting cells
#386Methods and compositions for modulating peripheral immune function
#387Method for detecting CD4+CD25+glycoprotein A33(GPA33)high and/or CD4+CD127-GPA33high T cells
#388METHOD FOR INDUCING REGULATORY T CELL
#389SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#390SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#391Three-dimensional printed organs, devices, and matrices
#392Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using same
#393T REGULATORY CELLS AND USES THEREOF
#394Soluble mediator
#395Genetically modified genes and cells, and methods of using same for silencing virus gene expression
#396IL-23R ANTAGONISTS TO REPROGRAM INTRATUMORAL T REGULATORY CELLS INTO EFFECTOR CELLS
#397THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1
#398SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#399SECRETABLE VARIANT IMMUNOMODULATORY PROTEINS AND ENGINEERED CELL THERAPY
#400Modulatable switch for selection of donor modified cells
#401Methods of Isolating Naive Regulatory T Cells
#402STIMULATION OF THERAPEUTIC ANGIOGENESIS BY T REGULATORY CELLS
#403CELL THERAPY COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE COMPRISING REGULATORY T CELLS AS ACTIVE INGREDIENT
#404CELL
#405Cell
#406THERAPIES BASED ON CONTROL OF REGULATORY T CELL STABILITY AND FUNCTION VIA A NEUROPILIN-1:SEMAPHORIN AXIS
#407Generation and use in adoptive immunotherapy of stem cell-like memory T cells
#408Compositions comprising glucosylated hydroxymethylated bases
#409Compound, and method for producing regulatory T cells
#410T cells derived from umbilical cord blood
#411Compositions and methods for in vitro cultivation and/or expansion of regulatory T cells
#412REGULATORY T CELL POPULATIONS
#413Expansion of populations of T cells by the use of modified serum free media
#414METHODS FOR ENHANCING PROLIFERATION OF T REGULATORY CELLS
#415T cell receptors
#416ENGINEERED TREG CELLS
#417Biotin derivatives
#418Veto cells generated from memory T cells
#419Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
#420Methods for identifying hydroxylated bases
#421Method of hematopoietic stem cell transplants
#422ARTIFICIAL ANTIGEN PRESENTING CELLS AND METHODS OF USE
#423Antibodies, combinations comprising antibodies, biomarkers, uses and methods
#424Modulation of intestinal epithelial cell differentiation, maintenance and/or function through T cell action
#425Methods for manufacturing T cells
#426Selective oxidation of 5-methylcytosine by TET-family proteins
#427COMPOSITIONS AND METHODS FOR DIMINISHING AN IMMUNE RESPONSE
#428Use of specific regulatory T-cells to induce immune tolerance
#429Materials and methods for modifying the activity of T cells
#430Soluble mediator
#431Manipulated immunoregulatory element and immunity altered thereby
#432GENETIC ERASERS
#433Ex vivo generation of γδ Foxp3regulatory T cells and therapeutic uses thereof
#434Ex vivo generation of MHCII restricted CD4FOXP3regulatory T cells and therapeutic uses thereof
#435CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS
#436Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
#437Genetically modified T lymphocytes
#438Compositions and methods for performing magnetibuoyant separations
#439MODULATION OF T LYMPHOCYTES
#440COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS
#441METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
#442LOCALIZED IMMUNOSUPPRESSION VIA OPTOGENETICALLY CONTROLLED CELLS
#443Methods for distinguishing 5-hydroxymethylcytosine from 5-methylcytosine
#444SELECTIVE EXPANSION OF DIFFERENT SUBPOPULATIONS OF T CELLS BY THE ALTERATION OF CELL SURFACING SIGNALS AND SIGNAL RATIO
#445SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#446Use of apoptotic cells ex vivo to generate regulatory T cells
#447Modulatable switch for selection of donor modified cells
#448SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#449Selective oxidation of 5-methylcytosine by TET-family proteins
#450Cell
#451Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of same
#452USING MICROBIOTA METABOLITES TO DIFFERENTIATE NAÏVE T-CELLS AND RELATED METHODS TO INDUCE OR PREVENT INFLAMMATORY CONDITIONS
#453IMMUNE CELL SELECTION, EXPANSION, AND USE
#454Pharmaceutical composition for preventing or treating regulatory T cell-mediated diseases
#455Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)
#456Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase
#457Methods for printing organs and organoids
#458ICOS critically regulates the expansion and function of inflammatory human Th17 cells
#459PRODUCTS AND METHODS FOR ACTIVATING AND/OR EXPANDING T CELLS
#460Antigen-specific T cells for inducing immune tolerance
#461Method for regenerating T cells and applications thereof
#462Method for ex vivo expansion of regulatory T cells
#463Immune cell compositions and methods of using same
#464Perispinal perfusion by administration of T regulatory cells alone or in combination with angiogenic cell therapies
#465Regulatory T-cells, method for their isolation and uses
#466Compositions and methods for modulating an immune response
#467Mode of inducing renal transplant rejection on animals and its manufacturing approach
#468Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
#469OX40L-JAGGED-1 CHIMERIC POLYPEPTIDES AND USES THEREOF
#470Chimeric polypeptides and methods of altering the membrane localization of the same
#471Transforming growth factor-beta-responsive polypeptides and their methods for use
#472Methods for directed differentiation of pluripotent stem cells to immune cells
#473Detection of 5-hydroxymethylcytosine by glycosylation
#474Selection methods for genetically-modified T cells
#475Method for producing CD4-positive T cells from pluripotent stem cells
#476Treatment of cancer using chimeric antigen receptor and protein kinase a blocker
#477Labeling hydroxymethylated residues
#478Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity
#479Expanding cells in a bioreactor
#480Methods to protect transplanted tissue from rejection
#481Chimeric antigen receptor anti-inflammatory cells and methods of use
#482Compositions of hematopoietic stem cell transplants
#483REGULATORY T CELLS AND METHODS OF IDENTIFYING, OBTAINING AND USING TO TREAT IMMUNO-BASED DISORDERS
#484Method for ex-vivo expansion of regulatory T cells with enhanced suppressive function for clinical application in immune mediated diseases
#485Soluble mediator
#486SUBPOPULATION OF CD8+CD45RCLOW TREGS AND USES THEREOF
#487COMPOSITIONS FOR TREATING AN ARTHRITIC CONDITION
#488Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
#489Compositions and methods for modulating an immune response
#490BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS
#491Genetically modified anti-third party central memory T cells and use of same in immunotherapy
#492Methods of transplantation and disease treatment
#493Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
#494Methods for obtaining regulatory T cells and uses thereof
#495Methods for expansion or depletion of t-regulatory cells
#496Methods of sorting activated T cells using three dimensional dielectrophoresis
#497Selective oxidation of 5-methylcytosine by TET-family proteins
#498T-REG cell expansion
#499Compositions and methods for diminishing an immune response
#500POROUS SILICON MICROPARTICLE-BASED CANCER VACCINES AND METHODS FOR POTENTIATING ANTI-TUMOR IMMUNITY
#501CDCA1 epitope peptides for Th1 cells and vaccines containing the same
#502Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying Treg cells to produce therapeutic vaccine for treatment of diabetes type 1
#503Methods and kits for labeling, detection and isolation of Foxp3 regulatory T cells, isolated population of Foxp3 regulatory T cells thus obtained and uses thereof
#504Method for expansion of double negative regulatory T cells
#505Exosomes sourced from granulocytic myeloid-derived suppressor cells and application thereof
#506Antigen specific Tregs and related compositions, methods and systems
#507SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#508SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#509IMMUNOMODULATORY FUSION PROTEINS AND USES THEREOF
#510Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cells
#511ANTI-TUMOR VACCINE DERIVED FROM NORMAL CELLS
#512EXPANSION OF ALLOANTIGEN-REACTIVE REGULATORY T CELLS
#513Chimeric antigen receptors specific for carbonic acid anhydrase IX
#514Method for modifying T cell population
#515METHOD FOR THE IDENTIFICATION OF TRANSIENTLY FOXP3 NEGATIVE REGULATORY T-CELLS FROM HUMAN PERIPHERAL BLOOD
#516CS1 targeted chimeric antigen receptor-modified T cells
#517METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
#518GLYPICAN-3 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY
#519Therapeutic uses of CD137pos regulatory T cells
#520Pharmaceutical Compositions Comprising Soluble CD137
#521Tagged chimeric effector molecules and receptors thereof
#522Active CXCR4+ immune cells and methods for their production and use
#523Direct Method for providing Immunological Memory against HIV
#524Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cells
#525Cell therapy composition for preventing or treating immune disease comprising mesenchymal stem cells and immunoregulatory t-cells as active ingredient
#526Stimulation of therapeutic angiogenesis by T regulatory cells
#527Methods and compositions for T cell generation and uses thereof
#528Soluble mediator
#529Methods and compositions for modulating peripheral immune function
#530CDCA1 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#531COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS
#532Tumor infiltrating cells engineered to express a pro-inflammatory polypeptide
#533Discovery of regulatory T cells programmed to suppress an immune response
#534Methods and compositions for modulating T-GM cell function
#535Selective oxidation of 5-methylcytosine by TET-family proteins
#536POPULATION OF IMMUNOREGULATORY T CELLS SPECIFIC FOR AN IRRELEVANT ANTIGEN AND USES THEREOF FOR PREVENTING OR TREATING IMMUNE DISEASES
#537Use of PDL1 expressing cells to convert T cells into regulatory T cells
#538SUBSET-OPTIMIZED CHIMERIC ANTIGEN RECEPTOR-CONTAINING T-CELLS
#539Selective oxidation of 5-methylcytosine by TET-family proteins
#540USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL
#541CEACAM5 PEPTIDES FOR CROHN'S DISEASE
#542Biotin Derivatives
#543Isolated donor MHC-derived peptide and uses thereof
#544Agent for the treatment and or prophylaxis of an autoimmune disease and for the formation of regulatory T cells
#545Methods and Compositions for the Generation and Maintenance of Regulatory T Cells
#546CD8regulatory T-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract
#547Selective oxidation of 5-methylcytosine by TET-family proteins
#548Multi-lineage hematopoietic precursor cell production by genetic programming
#549CD8+ REGULATORY T-CELLS FOR USE IN THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES
#550METHOD FOR THE IDENTIFICATION OF CD4+ REGULATORY T-CELLS FOR USE IN THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES
#551Method for preparing and using cell ghost with active factors as synergist of lymphocyte in vitro culture
#552Regulatory T-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract
#553Methods of producing T cell populations enriched for stable regulatory T-cells
#554Isolated donor MHC-derived peptide and uses thereof
#555Enhancement of allogeneic hematopoietic stem cell transplantation
#556GALECTIN-9-SECRETING CELL, AND PRODUCTION METHOD AND USE OF THE SAME
#557EPICUTANEOUS IMMUNOREBALANCING
#558BIOMARKERS AND USES THEREOF
#559Modified natural killer T cells, pharmaceutical compositions and uses thereof
#560CELL
#561Cell
#562Cell
#563METHOD FOR TREATING CANCER BY ADMINISTERING ATP AND POLYMYXIN B
#564Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
#565Use of specific regulatory T-cells to induce immune tolerance
#566Regulatory B cells (tBREGS) and their use
#567VEHICLE FOR DELIVERING A COMPOUND TO A MUCOUS MEMBRANE AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#568METHODS OF EXPANDING T CELLS
#569T cell receptors
#570PRODUCTION AND THERAPEUTIC USES OF TH1-LIKE REGULATORY T CELLS
#571Allogeneic T-cell compositions for induction of IL-12
#572Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cells
#573Tolerogenic dendritic cells, method for their production and uses therof
#574Use of apoptotic cells ex vivo to generate regulatory T cells
#575T REGULATORY CELLS AND USES THEREOF
#576Use of ligands for the programmed cell death receptor conjugated to solid supports for cultivating human regulatory T cells
#577Compositions and methods for modulating an immune response
#578METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
#579Induced regulatory T cell and use thereof
#580Methods for expansion or depletion of T-regulatory cells
#581Method for generation of regulatory T-cells using factors secreted by iNKT cells
#582T cell balance gene expression, compositions of matters and methods of use thereof
#583ICOS critically regulates the expansion and function of inflammatory human Th17 cells
#584Therapies based on control of regulatory T cell stability and function via a neuropilin-1:semaphorin axis
#585Method of treating sepsis by administering a soluble CD52 glycoprotein
#586METHOD FOR POLYCLONAL STIMULATION OF T CELLS BY MOBILE NANOMATRICES
#587Enhancement of allogeneic hematopoietic stem cell transplantation
#588Isolation and Use of Human Regulatory T Cells
#589Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes
#590Human CD8 regulatory T cells inhibit GVHD and preserve general immunity in humanized mice
#591Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection
#592Acellular pro-tolerogenic compositions and process for making same
#593THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1
#594Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases
#595Use of PI3K M-TOR and AKT inhibitors to induce FOXP3 expression and generate regulatory T cells
#596COMPOSITIONS AND METHODS FOR DIMINISHING AN IMMUNE RESPONSE
#597METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC REGULATORY T CELLS
#598Expansion of alloantigen-reactive regulatory T cells
#599METHODS AND COMPOSITIONS FOR GENERATING AND USING ALLOGENEIC SUPPRESSOR CELLS
#600Method for increasing the proportion of animal cells secreting galectin-9